Abstract
Management of multiple sclerosis patients treated with peroral cladribine after four years from the beginning of treatment
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have